A new trading day began on Friday, with Gossamer Bio Inc (NASDAQ: GOSS) stock price up 5.56% from the previous day of trading, before settling in for the closing price of $1.26. GOSS’s price has ranged from $0.50 to $1.55 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -168.69%. With a float of $182.66 million, this company’s outstanding shares have now reached $227.22 million.
Let’s determine the extent of company efficiency that accounts for 145 employees. In terms of profitability, gross margin is 100.0%, operating margin of -43.96%, and the pretax margin is -40.41%.
Gossamer Bio Inc (GOSS) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Gossamer Bio Inc is 19.64%, while institutional ownership is 58.35%. The most recent insider transaction that took place on Jun 24 ’24, was worth 1,260. In this transaction Chief Medical Officer of this company sold 1,908 shares at a rate of $0.66, taking the stock ownership to the 196,891 shares. Before that another transaction happened on Jun 21 ’24, when Company’s President & CEO bought 372,000 for $0.67, making the entire transaction worth $250,282. This insider now owns 5,408,073 shares in total.
Gossamer Bio Inc (GOSS) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -168.69% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 15.97% during the next five years compared to 40.29% growth over the previous five years of trading.
Gossamer Bio Inc (NASDAQ: GOSS) Trading Performance Indicators
Here are Gossamer Bio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.71. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.43.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.24, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.47 in one year’s time.
Technical Analysis of Gossamer Bio Inc (GOSS)
Looking closely at Gossamer Bio Inc (NASDAQ: GOSS), its last 5-days average volume was 1.32 million, which is a drop from its year-to-date volume of 1.52 million. As of the previous 9 days, the stock’s Stochastic %D was 86.86%. Additionally, its Average True Range was 0.09.
During the past 100 days, Gossamer Bio Inc’s (GOSS) raw stochastic average was set at 72.15%, which indicates a significant decrease from 92.31% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 61.35% in the past 14 days, which was lower than the 92.67% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0305, while its 200-day Moving Average is $0.9958. However, in the short run, Gossamer Bio Inc’s stock first resistance to watch stands at $1.3700. Second resistance stands at $1.4100. The third major resistance level sits at $1.4650. If the price goes on to break the first support level at $1.2750, it is likely to go to the next support level at $1.2200. Now, if the price goes above the second support level, the third support stands at $1.1800.
Gossamer Bio Inc (NASDAQ: GOSS) Key Stats
With a market capitalization of 302.31 million, the company has a total of 227,302K Shares Outstanding. Currently, annual sales are 114,700 K while annual income is -56,530 K. The company’s previous quarter sales were 9,890 K while its latest quarter income was -36,640 K.
